Company: MIRA
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024077
Chunk: 24

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 8
Chunk 24
---
, if any,
within our control have been detected. The design of any system of controls also is based in part upon certain assumptions about the
likelihood of future events, and there can be no assurance that any control design will succeed in achieving its stated goals under all
potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance
with the policies or procedures may deteriorate.

Based
on this evaluation, the Certifying Officers have concluded that our disclosure controls and procedures were effective as of June 30,
2025.

Changes
in Internal Control over Financial Reporting

There
were no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange
Act, during our second quarter of 2025 that materially affected, or are reasonably likely to materially affect, our internal control
over financial reporting.

19

PART
II. OTHER INFORMATION

Item
1. Legal Proceedings

From
time to time, we may be named in claims arising in the ordinary course of business. Currently, no legal proceedings, government actions,
administrative actions, investigations, or claims are pending against us or involve us that, in the opinion of our management, could
reasonably be expected to have a material adverse effect on our business and financial condition.

We
anticipate that we will expend significant financial and managerial resources in the defense of our intellectual property rights in the
future if we believe that our rights have been violated. We also anticipate that we will expend significant financial and managerial
resources to defend against claims that our products and services infringe upon the intellectual property rights of third parties.

Item
1A. Risk Factors.

As
a smaller reporting company, information under this “Item 1A. Risk Factors” is not required to be presented.

Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

Item
3. Defaults upon Senior Securities.

None.

Item
4. Mine Safety Disclosures.

Not
applicable.

Item
5. Other Information.

Not
applicable.

20

Item
6. Exhibits.

    Number
     
    Description

    31.1*
     
    Certification
    of Chief Executive Officer Pursuant to Sarbanes-Oxley Section 302

    31.2*
     
    Certification
    of Interim Chief Financial Officer Pursuant to Sarbanes-Oxley